Preclinical, Clinical and Regulatory Consulting

Drug candidate selection and preparation for clinical testing requires that a comprehensive package of preclinical experimental data be collected and properly presented to regulatory agencies. Designing a clinical trial requires very careful and coordinated planning. These are always a team effort, and often require assistance from outside consultants.

Cytoscient offers consulting services to address many of the needs that arise in the drug development process. Cytoscient members have broad experience in the pharmacology, ADME, toxicology, and biomarker data requirements, as well as how to prepare these for FDA and EMA submissions. Our services adapt to your needs, and range from assisting in overall planning, reviewing preclinical data for suitability and completeness, through to designing and supervising clinical trials.